GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Alexion Pharmaceuticals, Inc. (ALXN) [hlAlert]

Rating:
Buy ALXN
up 939.27 %

Alexion Pharmaceuticals, Inc. (ALXN) rated Buy

Posted on: Friday,  Oct 5, 2007  9:25 AM ET by Banc of America Sec

Banc of America Sec rated Buy Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) on 10/05/2007, when the stock price was $17.30.
Since then, Alexion Pharmaceuticals, Inc. has gained 939.27% as of 12/11/2015's recent price of $179.82.
If you would have followed this Banc of America Sec's recommendation on ALXN, you would have gained 939.27% of your investment in 2989 days.

Alexion Pharmaceuticals develops pharmaceutical products for the treatment of heart disease, and inflammation, diseases of the immune system and cancer in humans. The company's lead product candidates are genetically altered antibodies that target specific diseases which arise when the human immune system induces undesired inflammation in the human body. These candidates are designed to block components of the human immune system which cause undesired inflammation while allowing beneficial components of the immune system to remain functional.

Integrity, objectivity and originality are cornerstones of the value–added research that we offer to corporate and institutional clients. As thought leaders, our goal is to help clients understand and adapt to changing economic conditions and events that drive markets, currencies, industries and companies worldwide. And we deliver innovative ideas based on rigorous primary research, sound principles and clear vision. Our research teams are organized by areas of expertise, from equities, fixed income and emerging markets to foreign exchange and global financial risk advisory – featuring many of the industry’s most respected analysts and economists. Through our private, password–protected Web portal, our clients have access to a comprehensive array of timely research and commentary, including: * U.S. and global economic updates and indicators * Federal budget and fiscal policy * Industry outlooks * Stock coverage and picks * Financial market strategies * Corporate bond issuer risk analysis
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/5/2007 9:25 AM Buy
None
17.30
as of 8/27/2015
1 Week down  -5.16 %
1 Month down  -5.81 %
3 Months up  11.21 %
1 YTD up  35.32 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy